Authors: Poon, GK Chen, Q Teffera, Y Ngui, JS Griffin, PR Braun, MP Doss, GA Freeden, C Stearns, RA Evans, DC Baillie, TA Tang, W

Citation: Gk. Poon et al., Bioactivation of diclofenac via benzoquinone imine intermediates-identification of urinary mercapturic acid derivatives in rats and humans, DRUG META D, 29(12), 2001, pp. 1608-1613

Authors: Butera, JA Antane, MM Antane, SA Argentieri, TM Freeden, C Graceffa, RF Hirth, BH Jenkins, D Lennox, JR Matelan, E Norton, NW Quagliato, D Sheldon, JH Spinelli, W Warga, D Wojdan, A Woods, M

Citation: Ja. Butera et al., Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-cyanoguanidine bioisosteres possessing in vivo bladderselectivity, J MED CHEM, 43(6), 2000, pp. 1187-1202

Authors: Gilbert, AM Antane, MM Argentieri, TM Butera, JA Francisco, GD Freeden, C Gundersen, EC Graceffa, RF Herbst, D Hirth, BH Lennox, JR McFarlane, G Norton, NW Quagliato, D Sheldon, JH Warga, D Wojdan, A Woods, M

Citation: Am. Gilbert et al., Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 2. Selective and potent benzylamino cyclobutenediones, J MED CHEM, 43(6), 2000, pp. 1203-1214

Authors: Wojdan, A Freeden, C Woods, M Oshiro, G Spinelli, W Colatsky, TJ Sheldon, JH Norton, NW Warga, D Antane, MM Antane, SA Butera, JA Argentieri, TM

Citation: A. Wojdan et al., Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and in vivo bladder instability in rat, J PHARM EXP, 289(3), 1999, pp. 1410-1418